PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS

Abstract: pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compa...

ver descrição completa

Detalhes bibliográficos

Autor principal:	M. V. Protsenko
Formato:	Artigo
Idioma:	Russo
Publicado em:	IRBIS LLC 2015-03-01
coleção:	Фармакоэкономика
Assuntos:	primary open-angle glaucoma pharmacoeconomic studies cost-utility analysis willingness-to-pay analysis cost minimization analysis budget impact analysis timolol brinzolamid
Acesso em linha:	https://www.pharmacoeconomics.ru/jour/article/view/38
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!